Skip to main content
Ellen Hukkelhoven

Ellen Hukkelhoven, PhD

Head of Biotechnology Investments, Perceptive Advisors
Ellen Hukkelhoven joined Perceptive in 2013 as a Senior Biotechnology Analyst. At Perceptive, she focuses on public and private development stage therapeutic companies. Ellen serves on the boards of MeiraGTx, Freenome, Kindbody, AavantiBio and Partner Therapeutics. She is also a member of the Board of Overseers of the Columbia Mailman School of Public Health. Prior to Perceptive, Ellen received her PhD in Cancer Biology from Memorial Sloan Kettering Cancer Center. During her tenure at MSKCC, she founded and built the life sciences division of InSITE, a top graduate fellowship program that helps early stage companies with their most pressing needs. Ellen graduated magna cum laude from Princeton University with degrees in molecular biology and finance.​

Double Helix


Supporting Bank Sponsor


Premier Sponsors

Conference Sponsors


Media Partner


Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.